Abstract Details

Title MRI Findings of BOLD: A Phase 2 Dose-Finding Study Using Adaptive Design and Modeling Methods for BAF312 in Relapsing-Remitting MS

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Guojun Zhao, MD (Division of Neurology)	No disclosure on file
Srikanth Bharatham (UCB Pharma)	No disclosure on file
	No disclosure on file
Francois Mercier	No disclosure on file
	No disclosure on file
Erik Wallstroem, MD, PhD (Sanofi)	Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��